The Health Economics of Genomic Technologies: A Growing Evidence Base on Value

James Buchanan (), Ilias Goranitis and Deirdre Weymann
Additional contact information
James Buchanan: Queen Mary University of London
Ilias Goranitis: The University of Melbourne
Deirdre Weymann: BC Cancer Research Institute

Applied Health Economics and Health Policy, 2025, vol. 23, issue 3, No 1, 335 pages

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40258-025-00970-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:23:y:2025:i:3:d:10.1007_s40258-025-00970-z

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-025-00970-z

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().